Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Dasatinib +1 More for T-Cell Lymphoblastic Leukemia
Recruiting1 awardPhase 2
Memphis, Tennessee
This trial is testing whether adding either dasatinib or venetoclax to the treatment of children and young adults with certain types of leukemia can improve their outcomes. The main goal is to see if
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.